Literature DB >> 12670481

trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression.

Kihwa Kang1, Wei Liu, Karen J Albright, Yeonhwa Park, Michael W Pariza.   

Abstract

The trans-10,cis-12 isomer of conjugated linoleic acid (CLA) has been shown to reduce body fat gain in mice. However, the underlying molecular mechanism is not well characterized. Here we report evidence that trans-10,cis-12 (t10c12) CLA inhibits preadipocyte differentiation. Treating differentiating 3T3-L1 preadipocytes with t10c12 CLA and conjugated nonadecadienoic acid (CNA, a 19-carbon CLA cognate) resulted in decreased intracellular triglyceride accumulation and mRNA levels of the adipogenic gene fatty acid synthase and adipocyte lipid binding protein. T10c12 CLA and CNA also reduced protein levels of adipocyte transcription factors, peroxisome proliferator-activated receptor gamma and CCAAT/enhancer binding protein alpha. Similarly, CLA reduced body fat gain and significantly inhibited the expression of PPAR gamma and its downstream target lipoprotein lipase in mouse adipose tissue. These observations indicate that CLA decreases body fat gain in part by inhibiting the differentiation of preadipocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670481     DOI: 10.1016/s0006-291x(03)00413-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Body fat-lowering effect of conjugated linoleic acid is not due to increased lipolysis.

Authors:  E Simón; M T Macarulla; A Fernández-Quintela; V M Rodríguez; M P Portillo
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

2.  Dietary conjugated linoleic acid increases endurance capacity and fat oxidation in mice during exercise.

Authors:  Wataru Mizunoya; Satoshi Haramizu; Tetsuro Shibakusa; Yuki Okabe; Tohru Fushiki
Journal:  Lipids       Date:  2005-03       Impact factor: 1.880

3.  Effect of conjugated linoleic acid type, treatment period, and dosage on differentiation of 3T3 cells.

Authors:  M L He; T M Hnin; H Kuwayama; P S Mir; E K Okine; H Hidari
Journal:  Lipids       Date:  2006-10       Impact factor: 1.880

4.  Conjugated linoleic acid and chromium lower body weight and visceral fat mass in high-fat-diet-fed mice.

Authors:  Arunabh Bhattacharya; M Mizanur Rahman; Roger McCarter; Marianne O'Shea; Gabriel Fernandes
Journal:  Lipids       Date:  2006-05       Impact factor: 1.880

Review 5.  Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity.

Authors:  J Mark Brown; Michael K McIntosh
Journal:  J Nutr       Date:  2003-10       Impact factor: 4.798

6.  Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice.

Authors:  Angela A Wendel; Aparna Purushotham; Li-Fen Liu; Martha A Belury
Journal:  Lipids       Date:  2009-09-25       Impact factor: 1.880

Review 7.  Antiobesity mechanisms of action of conjugated linoleic acid.

Authors:  Arion Kennedy; Kristina Martinez; Soren Schmidt; Susanne Mandrup; Kathleen LaPoint; Michael McIntosh
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

8.  Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes.

Authors:  Arion Kennedy; Soonkyu Chung; Kathleen LaPoint; Oluwatoyin Fabiyi; Michael K McIntosh
Journal:  J Nutr       Date:  2008-03       Impact factor: 4.798

9.  In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic acid on adipocyte inflammatory mediators.

Authors:  Aurelio Ocaña; Cristina Gómez-Asensio; Elena Arranz-Gutiérrez; Carlos Torres; Francisco Javier Señoráns; Guillermo Reglero
Journal:  Lipids Health Dis       Date:  2010-04-06       Impact factor: 3.876

10.  Effect of conjugated linoleic acids from beef or industrial hydrogenation on growth and adipose tissue characteristics of rats.

Authors:  Mao L He; Erasmus K Okine; Helen Napadajlo; Priya S Mir
Journal:  Nutr Metab (Lond)       Date:  2009-04-22       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.